In our main analyses, we found no significant differences in the risk of major cardiovascular outcome (composite of cardiovascular death, myocardial infarction, and stroke) between ACE inhibitor and either ARB or the combination of ACE inhibitor plus ARB. The gene discussed is ACE; the disease is Stroke.